A Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

NCT06001580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BR101

Sponsor

BioRay Pharmaceutical Co., Ltd.